Bankrupt opioid maker Purdue Pharma LP should scrap a planned $1.3 million bonus for its chief executive officer due to his alleged role in the deceptive marketing for the painkiller OxyContin, a group of U.S. senators said in a letter to the company.
CEO Craig Landau is a defendant in multiple lawsuits that accuse him of designing sales programs to boost prescriptions of the highly addictive drug, according to a letter Tuesday signed by 11 senators, including Democratic presidential candidates Bernie Sanders, Elizabeth Warren, Cory Booker and Amy Klobuchar.
Craig Landau
Source: Purdue Pharma via Business Wire
“The payment is based on aggressive performance ...
